These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 2474352)

  • 1. The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.
    Nicholson CD; Jackman SA; Wilke R
    Br J Pharmacol; 1989 Jul; 97(3):889-97. PubMed ID: 2474352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG; Poole-Wilson PA; Harding SE
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.
    Sebastião AM; Ribeiro JA
    Br J Pharmacol; 1988 May; 94(1):109-20. PubMed ID: 2456805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets.
    Simpson AW; Reeves ML; Rink TJ
    Biochem Pharmacol; 1988 Jun; 37(12):2315-20. PubMed ID: 2455518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.
    Fredholm BB; Sandberg G
    Br J Pharmacol; 1983 Dec; 80(4):639-44. PubMed ID: 6100843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The low KM-phosphodiesterase inhibitor denbufylline enhances neuronal excitability in guinea pig hippocampus in vitro.
    Sutor B; Alzheimer C; Ameri A; ten Bruggencate G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):349-56. PubMed ID: 1704105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of alkylxanthines and other phosphodiesterase inhibitors on adenosine-receptor mediated decrease in lipolysis and cyclic AMP accumulation in rat fat cells.
    Fredholm BB; Lindgren E
    Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):64-71. PubMed ID: 6322517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for adenosine A1 receptor action in rat jejunal mucosa.
    Reymann A; Gniess A
    Eur J Pharmacol; 1988 Apr; 149(1-2):155-8. PubMed ID: 2840297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Chloro-[3H]-adenosine binding in isolated rat kidney membranes.
    Wu PH; Churchill PC
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):83-7. PubMed ID: 2408594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine inhibits the positive inotropic effect of 3-isobutyl-1-methylxanthine in papillary muscles without effect on cyclic AMP or cyclic GMP.
    Böhm M; Brückner R; Neumann J; Nose M; Schmitz W; Scholz H
    Br J Pharmacol; 1988 Apr; 93(4):729-38. PubMed ID: 2455577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors.
    Choi OH; Shamim MT; Padgett WL; Daly JW
    Life Sci; 1988; 43(5):387-98. PubMed ID: 2456442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.
    Dent G; Giembycz MA; Rabe KF; Barnes PJ
    Br J Pharmacol; 1991 Jun; 103(2):1339-46. PubMed ID: 1653070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation.
    Moritoki H; Matsugi T; Takase H; Ueda H; Tanioka A
    Br J Pharmacol; 1990 Jul; 100(3):569-75. PubMed ID: 2167736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline-like properties of xanthine analogs.
    Levallois C; Bonnafous JC; Francoise MA; Sablayrolles C; Chapat JP; Mani JC
    Biochem Pharmacol; 1984 Jul; 33(14):2253-7. PubMed ID: 6087821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the low intrinsic activity of adenosine and its analogs at low affinity (A2) adenosine receptors in rat cerebral cortex.
    Bazil CW; Minneman KP
    J Neurochem; 1986 Aug; 47(2):547-53. PubMed ID: 3016175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of high affinity and low affinity adenosine binding sites in human cerebral cortex.
    John D; Fox IH
    Adv Exp Med Biol; 1986; 195 Pt B():57-69. PubMed ID: 2429512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function.
    Weston MC; Anderson N; Peachell PT
    Br J Pharmacol; 1997 May; 121(2):287-95. PubMed ID: 9154339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.